• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

量化 COVID-19 大流行期间政府干预和病毒突变对传播优势的影响。

Quantifying the effect of government interventions and virus mutations on transmission advantage during COVID-19 pandemic.

机构信息

JC School of Public Health and Primary Care, the Chinese University of Hong Kong, Hong Kong, China.

JC School of Public Health and Primary Care, the Chinese University of Hong Kong, Hong Kong, China; CUHK Shenzhen Research Institute, Shenzhen, China.

出版信息

J Infect Public Health. 2022 Mar;15(3):338-342. doi: 10.1016/j.jiph.2022.01.020. Epub 2022 Feb 4.

DOI:10.1016/j.jiph.2022.01.020
PMID:35167995
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8813191/
Abstract

BACKGROUND

The coronavirus disease 2019 (COVID-19) pandemic has become a major public health threat. This study aims to evaluate the effect of virus mutation activities and policy interventions on COVID-19 transmissibility in Hong Kong.

METHODS

In this study, we integrated the genetic activities of multiple proteins, and quantified the effect of government interventions and mutation activities against the time-varying effective reproduction number R.

FINDINGS

We found a significantly positive relationship between R and mutation activities and a significantly negative relationship between R and government interventions. The results showed that the mutations that contributed most to the increase of R were from the spike, nucleocapsid and ORF1b genes. Policy of prohibition on group gathering was estimated to have the largest impact on mitigating virus transmissibility. The model explained 63.2% of the R variability with the R.

CONCLUSION

Our study provided a convenient framework to estimate the effect of genetic contribution and government interventions on pathogen transmissibility. We showed that the S, N and ORF1b protein had significant contribution to the increase of transmissibility of SARS-CoV-2 in Hong Kong, while restrictions of public gathering and suspension of face-to-face class are the most effective government interventions strategies.

摘要

背景

2019 年冠状病毒病(COVID-19)大流行已成为主要的公共卫生威胁。本研究旨在评估病毒突变活动和政策干预对香港 COVID-19 传染性的影响。

方法

本研究整合了多种蛋白的遗传活性,并量化了政府干预和突变活动对时变有效繁殖数 R 的影响。

结果

我们发现 R 与突变活动呈显著正相关,R 与政府干预呈显著负相关。结果表明,对 R 增加贡献最大的突变来自刺突蛋白、核衣壳蛋白和 ORF1b 基因。禁止群体聚集的政策被估计对减轻病毒传播的影响最大。该模型用 R 解释了 63.2%的 R 变异性。

结论

本研究提供了一个方便的框架来估计遗传贡献和政府干预对病原体传染性的影响。我们表明,S、N 和 ORF1b 蛋白对 SARS-CoV-2 在香港的传染性增加有显著贡献,而公众集会的限制和面对面课程的暂停是最有效的政府干预策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5aa/8813191/537fc4943539/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5aa/8813191/537fc4943539/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5aa/8813191/537fc4943539/gr1_lrg.jpg

相似文献

1
Quantifying the effect of government interventions and virus mutations on transmission advantage during COVID-19 pandemic.量化 COVID-19 大流行期间政府干预和病毒突变对传播优势的影响。
J Infect Public Health. 2022 Mar;15(3):338-342. doi: 10.1016/j.jiph.2022.01.020. Epub 2022 Feb 4.
2
Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study.非药物干预措施对 2019 年冠状病毒病和流感在香港的影响评估:一项观察性研究。
Lancet Public Health. 2020 May;5(5):e279-e288. doi: 10.1016/S2468-2667(20)30090-6. Epub 2020 Apr 17.
3
Modelling the association between COVID-19 transmissibility and D614G substitution in SARS-CoV-2 spike protein: using the surveillance data in California as an example.基于加利福尼亚州监测数据的 SARS-CoV-2 刺突蛋白 D614G 突变与新冠病毒传播能力关联性建模:一项观察性研究。
Theor Biol Med Model. 2021 Mar 9;18(1):10. doi: 10.1186/s12976-021-00140-3.
4
Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.关注的紧急 SARS-CoV-2 变异株:用于快速检测和监测的新型多重实时 RT-PCR 检测方法。
Microbiol Spectr. 2022 Feb 23;10(1):e0251321. doi: 10.1128/spectrum.02513-21.
5
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
6
Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.香港 3 波新冠疫情期间不明 SARS-CoV-2 感染的血清流行率。
JAMA Netw Open. 2021 Nov 1;4(11):e2132923. doi: 10.1001/jamanetworkopen.2021.32923.
7
Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.ACE2 表达中的遗传变异性对 SARS-CoV-2 刺突 D614G 突变进化动态的影响。
Genes (Basel). 2020 Dec 24;12(1):16. doi: 10.3390/genes12010016.
8
Exploring the Interaction between E484K and N501Y Substitutions of SARS-CoV-2 in Shaping the Transmission Advantage of COVID-19 in Brazil: A Modeling Study.探讨 SARS-CoV-2 中 E484K 和 N501Y 取代物在塑造 COVID-19 在巴西传播优势中的相互作用:一项建模研究。
Am J Trop Med Hyg. 2021 Sep 27;105(5):1247-1254. doi: 10.4269/ajtmh.21-0412.
9
Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.SARS-CoV-2 包膜、膜、核衣壳和刺突结构蛋白在大流行开始到 2020 年 9 月期间的演变:按流行病学周进行的全球和区域方法。
Viruses. 2021 Feb 4;13(2):243. doi: 10.3390/v13020243.
10
Surveillance Metrics of SARS-CoV-2 Transmission in Central Asia: Longitudinal Trend Analysis.中亚地区 SARS-CoV-2 传播的监测指标:纵向趋势分析。
J Med Internet Res. 2021 Feb 3;23(2):e25799. doi: 10.2196/25799.

引用本文的文献

1
Predictive evolutionary modelling for influenza virus by site-based dynamics of mutations.基于突变位点动力学的流感病毒预测进化建模。
Nat Commun. 2024 Mar 21;15(1):2546. doi: 10.1038/s41467-024-46918-0.
2
Effectiveness of social distancing measures and lockdowns for reducing transmission of COVID-19 in non-healthcare, community-based settings.社交距离措施和封锁措施在减少非医疗、社区环境中的 COVID-19 传播方面的效果。
Philos Trans A Math Phys Eng Sci. 2023 Oct 9;381(2257):20230132. doi: 10.1098/rsta.2023.0132. Epub 2023 Aug 23.

本文引用的文献

1
SARS-CoV-2 variants, spike mutations and immune escape.SARS-CoV-2 变体、刺突突变和免疫逃逸。
Nat Rev Microbiol. 2021 Jul;19(7):409-424. doi: 10.1038/s41579-021-00573-0. Epub 2021 Jun 1.
2
Differential Influence of Age on the Relationship between Genetic Mismatch and A(H1N1)pdm09 Vaccine Effectiveness.年龄对遗传错配与 A(H1N1)pdm09 疫苗效力关系的影响差异。
Viruses. 2021 Apr 4;13(4):619. doi: 10.3390/v13040619.
3
Modelling the association between COVID-19 transmissibility and D614G substitution in SARS-CoV-2 spike protein: using the surveillance data in California as an example.
基于加利福尼亚州监测数据的 SARS-CoV-2 刺突蛋白 D614G 突变与新冠病毒传播能力关联性建模:一项观察性研究。
Theor Biol Med Model. 2021 Mar 9;18(1):10. doi: 10.1186/s12976-021-00140-3.
4
SARS-CoV-2 spike D614G change enhances replication and transmission.SARS-CoV-2 刺突蛋白 D614G 突变增强了复制和传播能力。
Nature. 2021 Apr;592(7852):122-127. doi: 10.1038/s41586-021-03361-1. Epub 2021 Feb 26.
5
The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories.非药物干预措施对 130 个国家和地区的 SARS-CoV-2 传播的影响。
BMC Med. 2021 Feb 5;19(1):40. doi: 10.1186/s12916-020-01872-8.
6
Quantifying the transmission advantage associated with N501Y substitution of SARS-CoV-2 in the UK: an early data-driven analysis.量化 N501Y 取代 SARS-CoV-2 在英国的传播优势:一项早期基于数据的分析。
J Travel Med. 2021 Feb 23;28(2). doi: 10.1093/jtm/taab011.
7
In silico prediction of influenza vaccine effectiveness by sequence analysis.基于序列分析的流感疫苗效力的计算机预测。
Vaccine. 2021 Feb 12;39(7):1030-1034. doi: 10.1016/j.vaccine.2021.01.006. Epub 2021 Jan 19.
8
Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020.2020 年 10 月至 11 月英国 SARS-CoV-2 N501Y 突变株的早期传播能力评估。
Euro Surveill. 2021 Jan;26(1). doi: 10.2807/1560-7917.ES.2020.26.1.2002106.
9
Viral targets for vaccines against COVID-19.针对 COVID-19 的疫苗的病毒靶点。
Nat Rev Immunol. 2021 Feb;21(2):73-82. doi: 10.1038/s41577-020-00480-0. Epub 2020 Dec 18.
10
Study on SARS-CoV-2 transmission and the effects of control measures in China.中国 SARS-CoV-2 传播及防控措施效果研究。
PLoS One. 2020 Nov 30;15(11):e0242649. doi: 10.1371/journal.pone.0242649. eCollection 2020.